thiazolidinediones drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| thiazolidinediones | targets | AMPK | — | 1 |
| thiazolidinediones | associated_with | diabetes | — | 1 |
| thiazolidinediones | regulates | insulin sensitivity | — | 1 |
| thiazolidinediones | targets | PPARG | — | 1 |
| thiazolidinediones | regulates | PPARγ | — | 1 |
| thiazolidinediones | protective_against | type 2 diabetes | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- Possible relationship between common genetic variation and white matter development in a pilot study of preterm infants. (2016)
- Pioglitazone blocks ethanol induction of microglial activation and immune responses in the hippocampus, cerebellum, and cerebral cortex in a mouse model of fetal alcohol spectrum disorders. (2015)
- The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013)
- Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. (2012)
- Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. (2011)
- Genetics of psychiatric disorders methods: molecular approaches. (2010)
- Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease. (2009)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| thiazolidinediones | drug | 7 | 11 |
| pparγ agonists | drug | — | — |
| tzds | drug | — | — |